Companies Dominating the Elastomeric Infusion Pumps Market
- B. Braun SE
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Coloplast Group
- Shanghai Kindly Medical Instrument Co., Ltd.
- SOOIL Developments Co., Ltd
- Micrel Medical Devices SA
- Leventon, S.A.U.
- Ace-medical
- Medtronic
- Avanos Medical, Inc.
- Baxter
- Vygon
- Intera Oncology
Browse Key Market Insights with Data Illustration:
In the News
December ,2022- The Medtronic Extended infusion set, the first and only infusion set that may be worn with Medtronic insulin pumps for up to 7 days, has been licensed by Health Canada, according to Medtronic Canada. It is licensed for subcutaneous insulin infusion in the management of diabetes mellitus.
March ,2023-Immucor, Inc. is fully acquired by Werfen, extending its dominant position in specialized diagnostics. stated in November 2022 that a deal to buy Immucor, Inc. for about USD 2 billion had been achieved.
